2022
DOI: 10.3389/fpubh.2022.941773
|View full text |Cite
|
Sign up to set email alerts
|

No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loads

Abstract: In the face of a long-running pandemic, understanding the drivers of ongoing SARS-CoV-2 transmission is crucial for the rational management of COVID-19 disease burden. Keeping schools open has emerged as a vital societal imperative during the pandemic, but in-school transmission of SARS-CoV-2 can contribute to further prolonging the pandemic. In this context, the role of schools in driving SARS-CoV-2 transmission acquires critical importance. Here we model in-school transmission from first principles to invest… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 59 publications
0
2
0
Order By: Relevance
“…NPIs complement vaccines in slowing viral evolution by limiting the transmission of novel vaccine-evading mutants (Figure 3). In the real world, vaccinal efficacy is degraded by two phenomena: the pharmacokinetic decay of neutralizing antibody titers and the rate of evolution of immune evasion by the virus (see [42] and Supplemental Text Section S8 in [43] for more details). We examined the hypothetical case of a vaccine whose efficacy was not degraded by immune-evading variants to identify the rate of vaccination required to prevent the generation of novel variants (Figure 4).…”
Section: Discussionmentioning
confidence: 99%
“…NPIs complement vaccines in slowing viral evolution by limiting the transmission of novel vaccine-evading mutants (Figure 3). In the real world, vaccinal efficacy is degraded by two phenomena: the pharmacokinetic decay of neutralizing antibody titers and the rate of evolution of immune evasion by the virus (see [42] and Supplemental Text Section S8 in [43] for more details). We examined the hypothetical case of a vaccine whose efficacy was not degraded by immune-evading variants to identify the rate of vaccination required to prevent the generation of novel variants (Figure 4).…”
Section: Discussionmentioning
confidence: 99%
“…An early intervention method that can target the initial dominant infection site (i.e., the nasopharynx) is imperative for limiting asymptomatic transmission (Van Egeren et al, 2022) of the exhaled pathogenic particulates as well as for preventing systemic lower airway progression of the disease in a host, aggravating toward severe illness (He et al, 2020;Sungnak et al, 2020). Of critical interest here: based on the brisk pace at which lower airway infections often ensue after the emergence of initial symptoms, it has been conjectured that the nasopharynx also acts as the seeding zone for the spread of a respiratory viral disease to the lungs via lower airway aspiration of virus-laden boluses of nasopharyngeal fluids (Hou et al, 2020;Basu et al, 2022a;Chen et al, 2022).…”
Section: Introductionmentioning
confidence: 99%